|
|
||||||||
1 Pharmacology and Molecular
Biology Research Laboratories,
The cardiovascular roles of platelet-derived
growth factor (PDGF) were examined in anesthetized rats by monitoring
blood pressure and in isolated blood vessels and heart preparations.
Intravenous injection of PDGF-BB lowered blood pressure. The decrease
in systolic pressure was greater than that in diastolic pressure, so
the pulse pressure decreased. PDGF-AA and -AB, other isoforms of PDGF,
did not have any effect on blood pressure. Pretreatment of rats with N
-nitro-L-arginine
methyl ester (L-NAME), an
inhibitor of nitric oxide (NO) synthase, shortened duration of the
hypotensive effect of PDGF-BB. The administration of
L-arginine with
L-NAME partially prevented the
effect of L-NAME. PDGF-BB
relaxed aortic rings precontracted with phenylephrine with a 50%
effective concentration of 3 ng/ml. In contrast, in isolated mesenteric
vascular preparations, the vasodilating activity of PDGF-BB was
observed only at a high concentration (>12.5 ng/ml). In isolated
heart preparations, PDGF-BB had no effect on the beat rate or
contractile activity. These results suggest a new role of PDGF-BB that
may contribute to the regulation in circulation through the increase in
macrovascular compliance mediated by NO.
nitric oxide; endothelium; macrovessel; hypotension; 
-receptor
This article has been cited by other articles:
![]() |
C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamawaki, K. Sato, M. Hori, H. Ozaki, S.-I. Nakamura, H. Nakayama, K. Doi, and H. Karaki Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H318 - H323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |